Beijing Mabworks Biotech Co., Ltd.

This study tests a drug called MIL62 in 102 adults with neuromyelitis optica spectrum disorder (NMOSD), a rare autoimmune disease that attacks the nerves in the eyes and spinal cord. The goal is to see if MIL62 can safely prevent relapses (sudden worsening of symptoms). Participa…

This study tests an experimental drug called MIL62 in 120 adults with active lupus. The goal is to see if it can reduce disease activity better than a placebo. Participants must have moderate to severe lupus and be on a stable treatment plan.